| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
18.94 |
% |
10.6019/CHEMBL4513141 |
| Babesia divergens |
Babesia divergens |
IC50 |
nan |
None |
10.1128/aac.00225-07 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Brugia malayi |
Brugia malayi |
Mortality |
9.0 |
% |
10.1021/jm0492655 |
| Brugia malayi |
Brugia malayi |
Mortality |
16.0 |
% |
10.1021/jm0492655 |
| Caenorhabditis elegans |
Caenorhabditis elegans |
Inhibition |
nan |
% |
10.1039/C9MD00064J |
| Candida albicans |
Candida albicans |
Inhibition |
2.62 |
% |
10.6019/CHEMBL4513141 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
42.52 |
% |
10.6019/CHEMBL4513141 |
| Echinococcus granulosus |
Thioredoxin glutathione reductase |
Inhibition |
nan |
% |
10.1039/C9MD00064J |
| Echinococcus multilocularis |
Echinococcus multilocularis |
Activity |
2.96 |
g |
10.1128/aac.00553-08 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
56330.0 |
nM |
10.1016/j.bmcl.2011.10.028 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
56330.0 |
nM |
10.1016/s0960-894x(00)00619-3 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
56330.0 |
nM |
10.1016/s0960-894x(02)00346-3 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
56533.4 |
nM |
10.1016/j.bmcl.2013.05.012 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
56533.4 |
nM |
10.1016/j.ejmech.2017.05.058 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
56600.0 |
nM |
10.1016/j.ejmech.2010.03.050 |
| Escherichia coli |
Escherichia coli |
Inhibition |
1.87 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Potency |
89125.1 |
nM |
None |
| Escherichia coli K-12 |
Methionine aminopeptidase |
IC50 |
10000.0 |
nM |
10.1021/jm050476z |
| Escherichia coli K-12 |
Methionine aminopeptidase |
Inhibition |
15.45 |
% |
10.1021/jm050476z |
| Escherichia coli K-12 |
Methionine aminopeptidase |
Inhibition |
nan |
% |
10.1021/jm050476z |
| Giardia |
Giardia |
Potency |
516.1 |
nM |
None |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
0.018 |
ug.mL-1 |
10.1128/aac.00225-07 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
0.019 |
ug.mL-1 |
10.1128/aac.00225-07 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
37.0 |
nM |
10.1016/j.bmc.2008.12.059 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
37.0 |
nM |
10.1016/j.bmcl.2011.10.028 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
37.0 |
nM |
10.1016/j.bmcl.2013.05.012 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
37.0 |
nM |
10.1016/j.ejmech.2010.03.050 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
37.0 |
nM |
10.1016/j.ejmech.2012.03.014 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
37.0 |
nM |
10.1016/j.ejmech.2017.05.058 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
37.0 |
nM |
10.1016/j.ejmech.2020.113110 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
37.0 |
nM |
10.1016/s0960-894x(00)00619-3 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
37.0 |
nM |
10.1016/s0960-894x(02)00346-3 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
47.0 |
nM |
10.1016/j.ejmech.2020.113110 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
54.0 |
nM |
10.1016/j.ejmech.2020.113110 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
55.0 |
nM |
10.1021/acs.jmedchem.0c00910 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
137.0 |
nM |
10.1016/j.ejmech.2020.113110 |
| Giardia intestinalis |
Giardia intestinalis |
IC50 |
277.0 |
nM |
10.1016/j.ejmech.2020.113110 |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
2229.7 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
8876.6 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
14581.0 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile salt export pump |
AC50 |
300000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Caco-2 |
Papp |
1.99 |
ucm/s |
10.1016/j.ejmech.2012.03.014 |
| Homo sapiens |
Caco-2 |
Papp |
3.14 |
ucm/s |
10.1016/j.ejmech.2012.03.014 |
| Homo sapiens |
Caco-2 |
Ratio |
0.74 |
None |
10.1016/j.ejmech.2012.03.014 |
| Homo sapiens |
Caco-2 |
Ratio |
1.35 |
None |
10.1016/j.ejmech.2012.03.014 |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
398.11 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
30000.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
30000.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C8 |
IC50 |
30000.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
30000.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
30000.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2J2 |
Activity |
29.3 |
% |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2J2 |
Activity |
65.5 |
% |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
30000.0 |
nM |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA dC->dU-editing enzyme APOBEC-3G |
Potency |
1000.0 |
nM |
None |
| Homo sapiens |
DNA dC->dU-editing enzyme APOBEC-3G |
Potency |
1122.0 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Geminin |
Potency |
452.8 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
508.1 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
730.8 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
819.9 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
Potency |
1584.9 |
nM |
None |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
Potency |
4466.8 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
HEK293 |
Potency |
2059.6 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
10447.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
41.78 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
58.77 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
70794.6 |
nM |
None |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
7.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
2059.6 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
1000.0 |
nM |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Methionine aminopeptidase 1 |
Inhibition |
nan |
% |
10.1016/j.bmcl.2010.05.093 |
| Homo sapiens |
Methionine aminopeptidase 2 |
Inhibition |
10.0 |
% |
10.1016/j.bmcl.2010.05.093 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscleblind-like protein 1 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide S receptor |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
2909.3 |
nM |
None |
| Homo sapiens |
PC-3M |
EC50 |
1150.0 |
nM |
10.1016/j.ejmech.2017.11.037 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1124/dmd.30.4.365 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
398.1 |
nM |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
1122.0 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
102.72 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
95.9 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Transcriptional regulator ERG |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
50.8 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
127.6 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
316.2 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
326.4 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
461.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
580.5 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
891.3 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
3.18 |
% |
10.6019/CHEMBL4513141 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
3770.0 |
nM |
10.6019/CHEMBL3392926 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
113060.0 |
nM |
10.6019/CHEMBL3392926 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
None |
10.1128/aac.00225-07 |
| Leishmania mexicana |
Leishmania mexicana |
IC50 |
nan |
None |
10.1016/j.ejmech.2010.03.050 |
| Mus musculus |
Indoleamine 2,3-dioxygenase 2 |
Inhibition |
55.0 |
% |
10.1016/j.bmcl.2012.10.010 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
P-glycoprotein 1 and 3 (MDR1a/MDR1b) |
Activity |
nan |
None |
10.1124/dmd.30.4.365 |
| Nippostrongylus brasiliensis |
Nippostrongylus brasiliensis |
Activity |
100.0 |
% |
10.1039/C9MD00064J |
| Nippostrongylus brasiliensis |
Nippostrongylus brasiliensis |
EC50 |
340.0 |
nM |
10.1021/np0102307 |
| Nippostrongylus brasiliensis |
Nippostrongylus brasiliensis |
EC50 |
340.0 |
nM |
10.1039/C9MD00064J |
| Nippostrongylus brasiliensis |
Nippostrongylus brasiliensis |
LC50 |
340.0 |
nM |
10.1016/j.bmcl.2005.11.072 |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
1095.3 |
nM |
None |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
3013.1 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
None |
10.1128/aac.00225-07 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
510.3 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
1613.7 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
8275.3 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
10417.9 |
nM |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
1.7 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Inositol monophosphatase 1 |
Potency |
28183.8 |
nM |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
1067.2 |
nM |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
10953.3 |
nM |
None |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.055 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.098 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.1113 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.1297 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.1935 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.245 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.2696 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.28 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.2875 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.3084 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.4081 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.592 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.593 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
3.48 |
ug ml-1 |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/0960-894X(96)00405-2 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
36000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
40300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
247.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
375.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
381.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
430.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
29.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
44.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
53.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
56.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
66.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
79.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
87.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
99.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
110.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
123.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
133.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
150.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
101.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
101.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
102.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
640.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
670.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
906.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
990.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
225.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
237.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
278.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
390.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
24330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
24670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
26000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
27330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.1 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.1 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
69.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1413.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1610.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1613.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
2206.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
31.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
31.3 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
33.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.47 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
125000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
128700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
134700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
106.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
112.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
141.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
198.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
11.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
11.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
7019.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
7738.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
10254.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12808.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
88.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
89.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
94.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
97.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.0 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.9 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
25.17 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
26.07 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
391300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
403300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
404700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
411000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
61.27 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
61.77 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.17 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
63.4 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
23.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
149.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
184.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
2.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
6.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
8.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
10.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
190.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
712.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
776.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1574.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
105.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
109.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
113.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
122.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1007330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1157330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1425000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1525330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.64 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.98 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.27 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.31 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
52000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
53700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
55000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
58000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
4930000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5030000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5370000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5640000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.0 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.33 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
141.23 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
141.53 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
141.93 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Tissue Severity Score |
nan |
None |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
13.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
14.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
17.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
22.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Viscosity |
2.07 |
None |
10.1016/s0960-894x(00)00619-3 |
| Rattus norvegicus |
Rattus norvegicus |
Viscosity |
7.04 |
None |
10.1016/s0960-894x(00)00619-3 |
| Rattus norvegicus |
Rattus norvegicus |
Viscosity |
nan |
None |
10.1016/s0960-894x(00)00619-3 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
7230.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
8730.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
10970.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
14570.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
4.415 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1188 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.38 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
23.24 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.01846 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
3.05 |
% |
10.6019/CHEMBL4513141 |
| Trichinella spiralis |
Trichinella spiralis |
Activity |
58.6 |
% |
10.1016/j.ejmech.2010.03.050 |
| Trichinella spiralis |
Trichinella spiralis |
Activity |
61.9 |
% |
10.1016/j.ejmech.2010.03.050 |
| Trichinella spiralis |
Trichinella spiralis |
Activity |
62.0 |
% |
10.1016/j.ejmech.2010.03.050 |
| Trichinella spiralis |
Trichinella spiralis |
Activity |
63.0 |
% |
10.1016/j.ejmech.2010.03.050 |
| Trichinella spiralis |
Trichinella spiralis |
Activity |
67.0 |
% |
10.1016/j.ejmech.2010.03.050 |
| Trichinella spiralis |
Trichinella spiralis |
Activity |
73.0 |
% |
10.1016/j.ejmech.2010.03.050 |
| Trichinella spiralis |
Trichinella spiralis |
Efficacy |
10.6 |
% |
10.1016/j.bmc.2007.06.017 |
| Trichinella spiralis |
Trichinella spiralis |
Efficacy |
10.6 |
% |
10.1016/j.ejmech.2010.09.050 |
| Trichinella spiralis |
Trichinella spiralis |
Efficacy |
10.7 |
% |
10.1016/j.bmc.2007.06.017 |
| Trichinella spiralis |
Trichinella spiralis |
Efficacy |
13.3 |
% |
10.1016/j.bmc.2007.06.017 |
| Trichinella spiralis |
Trichinella spiralis |
Efficacy |
14.8 |
% |
10.1016/j.bmc.2007.06.017 |
| Trichinella spiralis |
Trichinella spiralis |
Efficacy |
14.8 |
% |
10.1016/j.ejmech.2010.09.050 |
| Trichinella spiralis |
Trichinella spiralis |
Efficacy |
15.1 |
% |
10.1016/j.bmc.2007.06.017 |
| Trichinella spiralis |
Trichinella spiralis |
Efficacy |
17.4 |
% |
10.1016/j.bmc.2007.06.017 |
| Trichinella spiralis |
Trichinella spiralis |
Efficacy |
100.0 |
% |
10.1016/j.bmc.2007.06.017 |
| Trichinella spiralis |
Trichinella spiralis |
Reduction |
6.0 |
% |
10.1016/s0960-894x(00)00619-3 |
| Trichinella spiralis |
Trichinella spiralis |
Reduction |
13.0 |
% |
10.1016/s0960-894x(00)00619-3 |
| Trichinella spiralis |
Trichinella spiralis |
Reduction |
20.0 |
% |
10.1016/s0960-894x(00)00619-3 |
| Trichinella spiralis |
Trichinella spiralis |
Reduction |
30.0 |
% |
10.1016/s0960-894x(00)00619-3 |
| Trichinella spiralis |
Trichinella spiralis |
Viability |
34.0 |
% |
10.1016/s0960-894x(02)00346-3 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
1590.5 |
nM |
10.1016/j.bmc.2008.12.059 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
1590.5 |
nM |
10.1016/j.bmcl.2011.10.028 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
1590.5 |
nM |
10.1016/j.bmcl.2013.05.012 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
1590.5 |
nM |
10.1016/j.ejmech.2017.05.058 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
1592.0 |
nM |
10.1016/j.ejmech.2010.03.050 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
14700.0 |
nM |
10.6019/CHEMBL3392926 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
nan |
None |
10.1128/aac.00225-07 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
12320.0 |
nM |
10.6019/CHEMBL3392926 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
nan |
None |
10.1128/aac.00225-07 |
| None |
ADMET |
CL |
12.59 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
34.67 |
mL.min-1.g-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
83.18 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
PPB |
94.19 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
PPB |
95.43 |
% |
10.6019/CHEMBL3301361 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
3.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
NON-PROTEIN TARGET |
Anticonvulsant activity |
nan |
None |
10.1016/s0960-894x(03)00535-3 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
5.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
25.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
100.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
410.0 |
nM |
10.6019/CHEMBL3392926 |
| None |
NON-PROTEIN TARGET |
IC50 |
11310.0 |
nM |
10.6019/CHEMBL3392926 |
| None |
NON-PROTEIN TARGET |
Mortality |
nan |
None |
10.1021/jm0492655 |
| None |
NON-PROTEIN TARGET |
TIME |
0.0895 |
hr |
10.1016/j.ejmech.2011.03.017 |
| None |
NON-PROTEIN TARGET |
TIME |
0.12 |
hr |
10.1016/j.ejmech.2011.03.017 |
| None |
NON-PROTEIN TARGET |
TIME |
0.5095 |
hr |
10.1016/j.ejmech.2011.02.052 |
| None |
NON-PROTEIN TARGET |
TIME |
0.593 |
hr |
10.1016/j.ejmech.2011.02.052 |
| None |
NON-PROTEIN TARGET |
TIME |
0.8397 |
hr |
10.1016/j.ejmech.2011.02.052 |
| None |
NON-PROTEIN TARGET |
TIME |
0.889 |
hr |
10.1016/j.ejmech.2011.02.052 |
| None |
NON-PROTEIN TARGET |
TIME |
0.9208 |
hr |
10.1016/j.ejmech.2011.02.052 |
| None |
NON-PROTEIN TARGET |
TIME |
1.006 |
hr |
10.1016/j.ejmech.2011.02.052 |
| None |
No relevant target |
log1/S |
5.55 |
None |
10.1016/j.ejmech.2012.03.014 |
| None |
No relevant target |
LogD |
3.83 |
None |
10.1016/j.ejmech.2012.03.014 |
| None |
No relevant target |
LogD7.4 |
3.24 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
logKw |
1.95 |
None |
10.1016/j.ejmech.2012.03.014 |
| None |
No relevant target |
LogP |
3.07 |
None |
10.1016/s0960-894x(01)00214-1 |
| None |
No relevant target |
-log(solubility) |
3.69 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
3.82 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
4.89 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
5.72 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
6.12 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
6.31 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
6.42 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
7.31 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
Peff |
283.6 |
10'-6 cm/s |
10.1016/j.ejmech.2018.12.059 |
| None |
No relevant target |
permeability |
44.1 |
% |
10.1016/j.ejmech.2018.12.059 |
| None |
No relevant target |
pKa_A1 |
10.5 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
pKa_B1 |
5.88 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
Solubility |
0.52 |
ug.mL-1 |
10.1016/j.ejmech.2019.111990 |
| None |
No relevant target |
Solubility |
0.74 |
ug.mL-1 |
10.1016/j.ejmech.2019.111990 |
| None |
No relevant target |
Solubility |
0.75 |
ug.mL-1 |
10.1016/j.ejmech.2012.03.014 |
| None |
No relevant target |
Solubility |
2.2 |
ug.mL-1 |
10.1021/acs.jmedchem.2c00386 |
| None |
No relevant target |
Solubility |
2.3 |
ug.mL-1 |
10.1016/j.bmcl.2015.03.016 |
| None |
No relevant target |
Solubility |
983.0 |
nM |
10.1021/jm0706416 |
| None |
No relevant target |
Solubility |
1000.0 |
nM |
10.1016/j.bmcl.2021.128216 |
| None |
No relevant target |
Solubility |
1500.0 |
nM |
10.1021/acs.jmedchem.0c01152 |
| None |
No relevant target |
Solubility |
1600.0 |
nM |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
Solubility |
3000.0 |
nM |
10.1016/j.bmc.2010.02.013 |
| None |
No relevant target |
Solubility |
6100.0 |
nM |
10.1021/acs.jmedchem.0c01104 |
| None |
No relevant target |
Solubility |
6100.0 |
nM |
10.1021/jm500942v |
| None |
No relevant target |
Solubility |
100000.0 |
nM |
10.1021/acs.jmedchem.0c01104 |
| None |
No relevant target |
Solubility |
100000.0 |
nM |
10.1021/jm500942v |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
AbsAC50 |
15.37 |
uM |
None |
| None |
Unchecked |
Ac50 |
0.001367 |
uM |
None |
| None |
Unchecked |
Ac50 |
0.01219 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.086 |
uM |
None |
| None |
Unchecked |
Ac50 |
4.324 |
uM |
None |
| None |
Unchecked |
Ac50 |
4.852 |
uM |
None |
| None |
Unchecked |
Ac50 |
5.012 |
uM |
None |
| None |
Unchecked |
Ac50 |
6.108 |
uM |
None |
| None |
Unchecked |
Ac50 |
7.689 |
uM |
None |
| None |
Unchecked |
Ac50 |
8.913 |
uM |
None |
| None |
Unchecked |
Ac50 |
10.0 |
uM |
None |
| None |
Unchecked |
Ac50 |
15.34 |
uM |
None |
| None |
Unchecked |
AC50 |
3162.3 |
nM |
None |
| None |
Unchecked |
AC50 |
3981.1 |
nM |
None |
| None |
Unchecked |
AC50 |
4851.6 |
nM |
None |
| None |
Unchecked |
AC50 |
5011.9 |
nM |
None |
| None |
Unchecked |
AC50 |
5443.6 |
nM |
None |
| None |
Unchecked |
AC50 |
6107.8 |
nM |
None |
| None |
Unchecked |
AC50 |
8912.5 |
nM |
None |
| None |
Unchecked |
AC50 |
8920.0 |
nM |
None |
| None |
Unchecked |
AC50 |
10000.0 |
nM |
None |
| None |
Unchecked |
Activity |
100.0 |
% |
10.1016/j.bmcl.2016.01.002 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.bmcl.2016.01.002 |
| None |
Unchecked |
EC50 |
580.0 |
nM |
10.1016/j.ejmech.2017.11.037 |
| None |
Unchecked |
Hepatotoxicity (acute) |
8.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
3.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
37.7 |
nM |
None |
| None |
Unchecked |
IC50 |
61.2 |
nM |
None |
| None |
Unchecked |
IC50 |
61.5 |
nM |
None |
| None |
Unchecked |
IC50 |
65.6 |
nM |
None |
| None |
Unchecked |
IC50 |
108.48 |
nM |
None |
| None |
Unchecked |
IC50 |
111.8 |
nM |
None |
| None |
Unchecked |
IC50 |
157.93 |
nM |
None |
| None |
Unchecked |
IC50 |
165.33 |
nM |
None |
| None |
Unchecked |
IC50 |
355.4 |
nM |
None |
| None |
Unchecked |
IC50 |
502.0 |
nM |
None |
| None |
Unchecked |
IC50 |
700.0 |
nM |
10.1128/aac.00355-07 |
| None |
Unchecked |
IC50 |
1276.4 |
nM |
None |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
None |
| None |
Unchecked |
IC50 |
12268.5 |
nM |
None |
| None |
Unchecked |
IC50 |
20000.0 |
nM |
None |
| None |
Unchecked |
IC50 |
30000.0 |
nM |
10.1021/acs.jmedchem.1c00354 |
| None |
Unchecked |
IC50 |
47000.0 |
nM |
10.1128/aac.00355-07 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
10.5 |
% |
10.1016/j.bmcl.2010.05.093 |
| None |
Unchecked |
Inhibition |
35.0 |
% |
10.1016/j.bmcl.2010.05.093 |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
14.1 |
nM |
None |
| None |
Unchecked |
Potency |
398.1 |
nM |
None |
| None |
Unchecked |
Potency |
501.2 |
nM |
None |
| None |
Unchecked |
Potency |
730.8 |
nM |
None |
| None |
Unchecked |
Potency |
891.3 |
nM |
None |
| None |
Unchecked |
Potency |
1122.0 |
nM |
None |
| None |
Unchecked |
Potency |
1258.9 |
nM |
None |
| None |
Unchecked |
Potency |
2511.9 |
nM |
None |
| None |
Unchecked |
Potency |
2909.3 |
nM |
None |
| None |
Unchecked |
Potency |
7943.3 |
nM |
None |
| None |
Unchecked |
Potency |
8912.5 |
nM |
None |
| None |
Unchecked |
Potency |
29092.9 |
nM |
None |
| None |
Unchecked |
Ratio EC50 |
2.0 |
None |
10.1016/j.ejmech.2017.11.037 |
| None |
Unchecked |
T1/2 |
8.0 |
hr |
10.1021/acs.jmedchem.0c00910 |